No abstract available
MeSH terms
-
Adenocarcinoma / metabolism
-
Adenocarcinoma of Lung
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / adverse effects*
-
Biomarkers, Tumor / metabolism*
-
Carcinoma, Squamous Cell / blood supply
-
Carcinoma, Squamous Cell / drug therapy
-
Carcinoma, Squamous Cell / metabolism*
-
Carcinoma, Squamous Cell / pathology
-
Gene Expression Regulation, Neoplastic
-
Hemorrhage / chemically induced
-
Humans
-
Lung Neoplasms / blood supply
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / metabolism*
-
Lung Neoplasms / pathology
-
Neoplasm Staging
-
Predictive Value of Tests
-
Prognosis
-
Receptors, Vascular Endothelial Growth Factor / drug effects
-
Receptors, Vascular Endothelial Growth Factor / metabolism*
-
Signal Transduction / drug effects*
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / drug effects
-
Vascular Endothelial Growth Factor A / metabolism*
-
Vascular Endothelial Growth Factor Receptor-1 / metabolism
-
Vascular Endothelial Growth Factor Receptor-2 / metabolism
-
Vascular Endothelial Growth Factor Receptor-3 / metabolism
Substances
-
Angiogenesis Inhibitors
-
Biomarkers, Tumor
-
Vascular Endothelial Growth Factor A
-
Receptors, Vascular Endothelial Growth Factor
-
Vascular Endothelial Growth Factor Receptor-1
-
Vascular Endothelial Growth Factor Receptor-2
-
Vascular Endothelial Growth Factor Receptor-3